Evidence map›Paper›PMID 34764739›Full record

ArticleSaudi journal of biological sciences2021

Pegylated Eu-enabled submicron alumina spheres as potential theranostics agent RD cell line as model.

Numrah Sultan, Syed Mujtaba Ul Hassan, Ahmat Khurshid, M Fakhar-E-Alam, Faisal Shahzad, Attaullah Shah, Muhammad Atif, Shafiq Ahmad, Muhammad Tamoor Masood

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Numrah SultanDepartment of Nuclear Engineering (DNE), PIEAS, Islamabad, Pakistan.
Syed Mujtaba Ul HassanDepartment of Metallurgical and Materials Engineering (DMME), PIEAS, Islamabad, Pakistan.
Ahmat KhurshidBiophotonic and Photomedicine Research Lab, DPAM, PIEAS, Islamabad, Pakistan.
M Fakhar-E-AlamDepartment of Physics, GC University Faisalabad, 38000 Pakistan.
Faisal ShahzadDepartment of Metallurgical and Materials Engineering (DMME), PIEAS, Islamabad, Pakistan.
Attaullah ShahNational Institute of Lasers and Optronics College, Pakistan Institute of Engineering and Applied Sciences (NILOP-C, PIEAS), Nilore 45650, Islamabad, Pakistan.
Muhammad AtifDepartment of Physics and Astronomy, College of Science, King Saud University, P O Box 2455, Riyadh 11451, Saudi Arabia.
Shafiq AhmadIndustrial Engineering Department, College of Engineering, King Saud University, P.O. Box 800, Riyadh 11421, Saudi Arabia.
Muhammad Tamoor MasoodInstitute for Materials Research and Innovation, University of Bolton, Bolton, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study is aimed to synthesis and evaluate PEGylated Eu enabled spherical alumina submicron particles (s-Al

methodsThis study is bisected into two parts, a) synthesis of PEGylated Eu enabled spherical alumina submicron particles (s-Al

resultsThe microstructure analysis, from the micrographs obtained from SEM, shows that the spherical alumina particles have a submicron size with narrow size distribution. The compositional analysis, as per EDX, confirms the presence of Oxygen, Aluminum and Europium in the particles. While, XRD analysis of s-Al

conclusionss-Al

Indexed as

BiocompatibleDopingEDX, Energy-dispersive X-ray spectroscopyFTIR, Fourier-transform infrared spectroscopyMTT3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromidePEG, Polyethylene glycolPhotoluminescenceRD, RhabdomyosarcomaSEM, Scanning electron microscopeTheranosticXRD, X-Ray Diffraction

Identifiers

PMID34764739
PMCPMC8568837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.